9 results about "Managing pain" patented technology

The present invention relates to a method for managing pain, such as acute pain, post-operative pain, or post-procedure pain, by administering meloxicam.

This document discusses, among other things, systems and methods for managing pain of a subject. A system includes a first sensor circuit to sense a first signal indicative of a functional state of the subject, a second sensor circuit to sense a second signal different from the first signal, and a controller circuit. The controller circuit may determine an operating mode of the second sensor circuit according to the sensed first signal, trigger the second senor circuit to sense the second signal under the determined operating mode, and generate a pain score using at least the second signal sensed under the determined operating mode. The pain score may be output to a patient or used for closed-loop control of a pain therapy.

The present application includes mitragynine analogues of Formula la or lb, compositions comprising said compounds and uses thereof, for example for treating and managing pain, for treating neurological or psychiatric diseases and disorders, for example treating an opioid addiction or opioid withdrawal symptoms.

The invention discloses a self-management digital platform for orthopedic pain patients, which comprises a platform rear end, a doctor end and a patient end, and is characterized in that the patient end comprises an initial information recording module, a rehabilitation plan module, a medication reminding module, a knowledge base module, a doctor-patient communication module and a social module; the information recording module is used for recording the pain condition of the patient and forming a treatment file in combination with the contents of the rehabilitation plan module and the medication reminding module; the rehabilitation planning module is used for providing rehabilitation action guidance according to the pain condition of the patient; the medicine taking reminding module is used for reminding the patient to take medicine; the knowledge base module is used for providing popular science knowledge; and the doctor-patient communication module is used for remote interaction between the patient and the doctor. The platform helps the patient to autonomously manage pain, rehabilitation training and daily health behaviors, the patient can scientifically perform pain management through recording, planning and reminding, and the pain rehabilitation data of the patient can be provided to the rear end of the platform as big data for research to provide reference for other patients.

Described herein are compounds of Formulae (I′)-(II′), compounds of Formulae (I)-(II) and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful for modulating opioid receptor activity. The provided compounds may have both agonistic and antagonistic effect on one or more opioid receptors. Methods of using the compounds for treating or managing pain are also described.

Aspects of the invention include methods of managing pain in a subject by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver a pain relieving effective amount of dexmedetomidine to a subject. In practicing methods according to certain embodiments, a transdermal delivery device having a dexmedetomidine composition is applied to a subject and is maintained in contact with the subject in a manner sufficient to deliver an amount of dexmedetomidine effective to manage pain in the subject. In some embodiments, methods include hydrating the subject, such as by administering a hydration fluid composition to the subject. Methods according to certain embodiments may also include co-administering an opioid to the subject. Also provided is a transdermal delivery device configured to deliver dexmedetomidine sufficient for practicing the subject methods, as well as kits containing the transdermal delivery device.

The present application includes mitragynine analogues of Formula la and lb, compositions comprising said compounds and uses thereof, for example for treating and managing pain, for treating neurological or psychiatric diseases and disorders, for example for treating an opioid addiction or opioid withdrawal symptoms. (Ia) or (Ib)

Aspects of the invention include methods of managing pain in a subject by applying a transdermal delivery device containing a dexmedetomidine composition that is formulated to deliver a pain-relieving effective amount of dexmedetomidine to the subject. In practicing methods according to certain embodiments, a transdermal delivery device having a dexmedetomidine composition is applied to a subject and maintained in contact with the subject in a manner sufficient to deliver an amount of dexmedetomidine effective to manage pain in the subject. In some embodiments, a method includes hydrating the subject, such as by administering a hydrated fluid composition to the subject. Methods according to certain embodiments may also include co-administering an opioid to the subject. Also provided is a transdermal delivery device configured to deliver dexmedetomidine sufficient for practicing the methods of the invention; and a kit containing the transdermal delivery device.

The present application includes mitragynine analogues of Formula la or lb, compositions comprising said compounds and uses thereof, for example for treating and managing pain, for treating neurological or psychiatric diseases and disorders, for example for treating an opioid addiction or opioid withdrawal symptoms. (Formula (Ia) or Formula (Ib))